Prof Dr. Inga Zerr

1-52 of 52
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2019 | Journal Article
    ​ ​Minikel EV, Kuhn E, Cocco AR, Vallabh SM, Hartigan CR, Reidenbach AG, et al. ​Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry​. ​​Molecular & Cellular Proteomics. ​2019;​18​(12):​​2388​-2400​. ​doi:10.1074/mcp.RA119.001702. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Khan Z, Nisar MA, Muzammil S, Zafar S, Zerr I, Rehman A. ​Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3Aer​. ​​Environmental Monitoring and Assessment. ​2019;​191​(8). ​doi:10.1007/s10661-019-7631-9. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Thüne K, Schmitz M, Villar-Piqué A, Altmeppen HC, Schlomm M, Zafar S, et al. ​The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers​. ​​Expert review of molecular diagnostics. ​2019;​19​(11):​​1007​-1018​. ​doi:10.1080/14737159.2019.1667231. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Vallabh SM, Nobuhara CK, Llorens F, Zerr I, Parchi P, Capellari S, et al. ​Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development​. ​​Proceedings of the National Academy of Sciences. ​2019;​116​(16):​​7793​-7798​. ​doi:10.1073/pnas.1901947116. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Minikel EV, Vallabh SM, Orseth MC, Brandel, Jean-Philippe, Haïk S, Laplanche, Jean-Louis, et al. ​Age at onset in genetic prion disease and the design of preventive clinical trials​. ​​Neurology. ​2019;​93​(2):​​e125​-e134​. ​doi:10.1212/WNL.0000000000007745. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Schmitz M, Candelise N, Kanata E, Llorens F, Thüne K, Villar-Piqué A, et al. ​Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency​. ​​Molecular Neurobiology. ​2019;​57​(4):​​1863​-1874​. ​doi:10.1007/s12035-019-01837-w. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Kranaster L, Hoyer C, Mindt S, Neumaier M, Müller N, Zill P, et al. ​The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid​. ​​European Archives of Psychiatry and Clinical Neuroscience. ​2019;​270​(7):​​911​-919​. ​doi:10.1007/s00406-019-01086-x. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Möhn N, Luo Y, Skripuletz T, Schwenkenbecher P, Zerr I, Lange P, et al. ​Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy​. ​​Fluids and Barriers of the CNS. ​2019;​16​(1). ​doi:10.1186/s12987-019-0148-3. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Zerr I, Villar-Piqué A, Schmitz VE, Poleggi A, Pocchiari M, Sánchez-Valle R, et al. ​Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients​. ​​Biomolecules. ​2019;​9​(12):​​800​. ​doi:10.3390/biom9120800. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Yagensky O, Kohansal-Nodehi M, Gunaseelan S, Rabe T, Zafar S, Zerr I, et al. ​Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity​. ​​eLife. ​2019;​8​. ​doi:10.7554/eLife.47498. 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​Villar-Piqué A, Schmitz M, Hermann P, Goebel S, Bunck T, Varges D, et al. ​Plasma YKL-40 in the spectrum of neurodegenerative dementia​. ​​Journal of Neuroinflammation. ​2019;​16​(1). ​doi:10.1186/s12974-019-1531-3. 
    ​Details  DOI  PMID  PMC 
  • 2018 | Journal Article
    ​ ​Kranaster L, Hoyer C, Aksay S, Bumb J, Müller N, Zill P, et al. ​Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study​. ​​Neuropsychobiology. ​2018;​77​(1):​​13​-22​. ​doi:10.1159/000491401. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Lewczuk P, Riederer P, O’Bryant SE, Verbeek MM, Dubois B, Visser PJ, et al. ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​. ​​The World Journal of Biological Psychiatry. ​2018;​19​(4):​​244​-328​. ​doi:10.1080/15622975.2017.1375556. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S, et al. ​Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance​. ​​Neurology. ​2018;​91​(4):​​e331​-e338​. ​doi:10.1212/WNL.0000000000005860. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Zerr I, Hermann P. ​Diagnostic challenges in rapidly progressive dementia​. ​​Expert Review of Neurotherapeutics. ​2018;​18​(10):​​761​-772​. ​doi:10.1080/14737175.2018.1519397. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Schmitz M, Villar-Piqué A, Llorens F, Gmitterová K, Hermann P, Varges D, et al. ​Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy​. ​​Molecular Neurobiology. ​2018;​56​(5):​​3476​-3483​. ​doi:10.1007/s12035-018-1313-4. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Villar-Piqué A, Schmitz M, Candelise N, Ventura S, Llorens F, Zerr I. ​Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases​. ​​Molecular Neurobiology. ​2018;​55​(9):​​7588​-7605​. ​doi:10.1007/s12035-018-0926-y. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Gmitterová K, Gawinecka J, Heinemann U, Valkovič P, Zerr I. ​DNA versus RNA oxidation in Parkinson’s disease: Which is more important?​. ​​Neuroscience Letters. ​2018;​662​:​​22​-28​. ​doi:10.1016/j.neulet.2017.09.048. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Gmitterová K, Gawinecka J, Llorens F, Varges D, Valkovič P, Zerr I. ​Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia​. ​​European Archives of Psychiatry and Clinical Neuroscience. ​2018;​270​(4):​​461​-470​. ​doi:10.1007/s00406-018-0928-9. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Maass F, Michalke B, Leha A, Boerger M, Zerr I, Koch, Jan-Christoph, et al. ​Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease​. ​​Journal of Neurochemistry. ​2018;​145​(4):​​342​-351​. ​doi:10.1111/jnc.14316. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N, et al. ​Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease​. ​​Molecular Neurobiology. ​2018;​55​(3):​​2249​-2257​. ​doi:10.1007/s12035-017-0479-5. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Llorens F, Thüne K, Martí E, Kanata E, Dafou D, Díaz-Lucena D, et al. ​Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis​. ​​PLOS Pathogens. ​2018;​14​(1):​​1​-33​. ​doi:10.1371/journal.ppat.1006802. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Albus A, Gold M, Bach, Jan-Philipp, Burg-Roderfeld M, Jördens M, Kirchhein Y, et al. ​Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein​. ​​PLoS One. ​2018;​13​(8):​​e0202954​. ​doi:10.1371/journal.pone.0202954. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Zafar S, Shafiq M, Andréoletti O, Zerr I. ​Animal TSEs and public health: What remains of past lessons?​. ​​PLoS Pathogens. ​2018;​14​(2):​​1​-6​. ​doi:10.1371/journal.ppat.1006759. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Thüne K, et al. ​Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases​. ​​Alzheimer's & Dementia: The Journal of the Alzheimer's Association. ​2017;​13​(6):​​710​-719​. ​doi:10.1016/j.jalz.2016.09.013. 
    ​Details  DOI  PMID  PMC 
  • 2017 | Journal Article | 
    ​ ​Llorens F, Fischer A, Thüne K, Sikorska B, Schmitz M, Tahir W, et al. ​Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease​. ​​Acta Neuropathologica Communication. ​2017;​5​(35):​​1​-20​. ​doi:10.1186/s40478-017-0431-y. 
    ​Details  DOI  PMID  PMC 
  • 2017 | Journal Article
    ​ ​Ahmed S, Mahmood Z, Javed A, Hashmi SN, Zerr I, Zafar S, et al. ​Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition​. ​​Journal of Molecular Neuroscience. ​2017;​62​(1):​​88​-98​. ​doi:10.1007/s12031-017-0915-z. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Khan Z, Rehman A, Nisar MA, Zafar S, Zerr I. ​Biosorption behavior and proteomic analysis of Escherichia coli P4 under cadmium stress​. ​​Chemosphere. ​2017;​174​:​​136​-147​. ​doi:10.1016/j.chemosphere.2017.01.132. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Llorens F, Zarranz, Juan-José, Fischer A, Zerr I, Ferrer I. ​Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations​. ​​Current Neurology and Neuroscience Reports. ​2017;​17​(4). ​doi:10.1007/s11910-017-0743-0. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Khan Z, Rehman A, Nisar MA, Zafar S, Hussain SZ, Zerr I, et al. ​Molecular basis of Cd+2 stress response in Candida tropicalis​. ​​Applied Microbiology and Biotechnology. ​2017;​101​(20):​​7715​-7728​. ​doi:10.1007/s00253-017-8503-2. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Krasnianski A, Bohling GT, Heinemann U, Varges D, Meissner B, Schulz-Schaeffer WJ, et al. ​Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany​. ​​Journal of Alzheimer's Disease. ​2017;​59​(1):​​329​-337​. ​doi:10.3233/JAD-161129. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Zafar S, Shafiq M, Younas N, Schmitz M, Ferrer I, Zerr I. ​Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer’s Disease​. ​​Journal of Alzheimer's Disease. ​2017;​59​(1):​​265​-275​. ​doi:10.3233/JAD-170237. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Zafar S, Younas N, Sheikh N, Tahir W, Shafiq M, Schmitz M, et al. ​Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease​. ​​Molecular Neurobiology. ​2017;. ​doi:10.1007/s12035-017-0589-0. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Ferreira D, Temido-Ferreira M, Vicente Miranda H, Batalha V, Coelho J, Szegö É, et al. ​α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B​. ​​Nature Neuroscience. ​2017;​20​(11):​​1569​-1579​. ​doi:10.1038/nn.4648. 
    ​Details  DOI 
  • 2017 | Journal Article | 
    ​ ​Llorens F, Schmitz M, Knipper T, Schmidt C, Lange P, Fischer A, et al. ​Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia​. ​​Frontiers in aging neuroscience. ​2017;​9​:​​1​-9​. ​doi:10.3389/fnagi.2017.00289. 
    ​Details  DOI  PMID  PMC 
  • 2016 | Journal Article
    ​ ​Frau-Méndez MA, Fernández-Vega I, Ansoleaga B, Blanco Tech R, Carmona Tech M, Antonio del Rio J, et al. ​Fatal familial insomnia: mitochondrial and protein synthesis machinery decline in the mediodorsal thalamus​. ​​Brain Pathology. ​2016;​27​(1):​​95​-106​. ​doi:10.1111/bpa.12408. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Tahir W, Zafar S, Llorens F, Arora AS, Thüne K, Schmitz M, et al. ​Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress​. ​​Molecular Neurobiology. ​2016;​55​(1):​​517​-537​. ​doi:10.1007/s12035-016-0294-4. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Mata A, Urrea L, Vilches S, Llorens F, Thüne K, Espinosa, Juan-Carlos, et al. ​Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies​. ​​Molecular Neurobiology. ​2016;​54​(8):​​6412​-6425​. ​doi:10.1007/s12035-016-0177-8. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Zerr I, Bandelow B, Wedekind D, Schneider A, Radenbach K, Wiltfang J, et al. ​Neuropsychiatrische Erkrankungen und Demenzen: ein interdisziplinärer Ansatz​. ​​Aktuelle Neurologie. ​2016;​43​(06):​​369​-371​. ​doi:10.1055/s-0042-106719. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Schmitz M, Dittmar K, Llorens F, Gelpi E, Ferrer I, Schulz-Schaeffer WJ, et al. ​Hereditary Human Prion Diseases: an Update​. ​​Molecular Neurobiology. ​2016;​54​(6):​​4138​-4149​. ​doi:10.1007/s12035-016-9918-y. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Schmitz M, Cramm M, Llorens F, Müller-Cramm D, Collins S, Atarashi R, et al. ​The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases​. ​​Nature Protocols. ​2016;​11​(11):​​2233​-2242​. ​doi:10.1038/nprot.2016.120. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Karch A, Llorens F, Schmitz M, Arora AS, Zafar S, Lange P, et al. ​Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia​. ​​Journal of Alzheimer's Disease. ​2016;​54​(4):​​1385​-1393​. ​doi:10.3233/JAD-160267. 
    ​Details  DOI 
  • 2016 | Journal Article | Letter Note
    ​ ​Zerr I, Bähr M. ​Is there a role of Tau in Huntington's disease?​. ​​Journal of Neurochemistry. ​2016;​139​(1):​​9​-10​. ​doi:10.1111/jnc.13762. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article
    ​ ​Engel KR, Obst K, Bandelow B, Dechent P, Gruber O, Zerr I, et al. ​Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls​. ​​European Archives of Psychiatry and Clinical Neuroscience. ​2015;​266​(6):​​557​-566​. ​doi:10.1007/s00406-015-0653-6. 
    ​Details  DOI 
  • 2015 | Journal Article
    ​ ​Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, et al. ​Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease​. ​​Neuropathology and Applied Neurobiology. ​2015;​41​(5):​​631​-645​. ​doi:10.1111/nan.12175. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Review
    ​ ​Schmitz M, Greis C, Ottis P, Silva CJ, Schulz-Schaeffer WJ, Wrede A, et al. ​Loss of Prion Protein Leads to Age-Dependent Behavioral Abnormalities and Changes in Cytoskeletal Protein Expression​ [book review]. ​​Molecular Neurobiology. ​2014;​50​(3):​​923​-936​. ​doi:10.1007/s12035-014-8655-3. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article | Research Paper | 
    ​ ​Schmitz M, Wulf K, Signore SC, Schulz-Schaeffer WJ, Kermer P, Baehr M, et al. ​Impact of the Cellular Prion Protein on Amyloid-beta and 3PO-Tau Processing​. ​​Journal of Alzheimer's Disease. ​2014;​38​(3):​​551​-565​. ​doi:10.3233/JAD-130566. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article
    ​ ​Haik S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, et al. ​Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial​. ​​The Lancet Neurology. ​2014;​13​(2):​​150​-158​. ​doi:10.1016/S1474-4422(13)70307-7. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2012 | Journal Article
    ​ ​Otto M, Esselmann H, Schulz-Schaeffer W, Neumann M, Schröter A, Ratzka P, et al. ​Decreased  β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease​. ​​Neurology. ​2012;​54​(5):​​1099​-1102​. ​doi:10.1212/wnl.54.5.1099. 
    ​Details  DOI 
  • 2011 | Journal Article
    ​ ​Otto M, Wiltfang J, Schütz E, Zerr I, Otto A, Pfahlberg A, et al. ​Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study​. ​​BMJ. ​2011;​316​(7131):​​577​-582​. ​doi:10.1136/bmj.316.7131.577. 
    ​Details  DOI 
  • 2010 | Journal Article | Letter Note
    ​ ​Schmidt CD, Plickert S, Summers DK, Zerr I. ​Pulvinar Sign in Wernicke's Encephalopathy​. ​​CNS Spectrums. ​2010;​15​(4):​​215​-218​. ​
    ​Details  PMID  PMC  WoS 
  • 2010 | Journal Article | Research Paper
    ​ ​Knöferle J, Ramljak S, Koch JC, Tönges L, Asif AR, Michel U, et al. ​TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP​. ​​Neurobiology of Disease. ​2010;​38​(3):​​395​-404​. ​doi:10.1016/j.nbd.2010.02.011. 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Book chapters & Review Articles & Preprints Papers (Journal & Conference)

Filter

Active filter:
Date Issued:  [2010 TO 2019]

Type

Subtype

Date issued

Author

Peer-Reviewed

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp01701
ID: 0000000
PREF: vancouver TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.